Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 31.24 Million USD | -40.03% |
| 2022 | 52.09 Million USD | -55.15% |
| 2021 | 116.16 Million USD | -29.97% |
| 2020 | 165.87 Million USD | 73.3% |
| 2019 | 95.71 Million USD | 39.24% |
| 2018 | 68.74 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 Q1 | 46.23 Million USD | -11.25% |
| 2023 FY | 31.24 Million USD | -40.03% |
| 2023 Q2 | 42.83 Million USD | -7.36% |
| 2023 Q3 | 37.77 Million USD | -11.8% |
| 2023 Q4 | 31.24 Million USD | -17.3% |
| 2022 FY | 52.09 Million USD | -55.15% |
| 2022 Q4 | 52.09 Million USD | -36.01% |
| 2022 Q3 | 81.41 Million USD | -22.8% |
| 2022 Q2 | 105.46 Million USD | -17.1% |
| 2022 Q1 | 127.21 Million USD | 9.52% |
| 2021 Q2 | 149.77 Million USD | -5.62% |
| 2021 Q1 | 158.68 Million USD | -4.34% |
| 2021 FY | 116.16 Million USD | -29.97% |
| 2021 Q4 | 116.16 Million USD | -17.7% |
| 2021 Q3 | 141.13 Million USD | -5.77% |
| 2020 Q4 | 165.87 Million USD | 84.1% |
| 2020 FY | 165.87 Million USD | 73.3% |
| 2020 Q3 | 90.1 Million USD | 1.11% |
| 2020 Q2 | 89.11 Million USD | -13.95% |
| 2020 Q1 | 103.56 Million USD | 8.2% |
| 2019 Q4 | 95.71 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 95.71 Million USD | 39.24% |
| 2018 FY | 68.74 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 96.546% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 45.587% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 97.267% |
| Cosmos Health Inc. | 66.29 Million USD | 52.873% |
| Dynavax Technologies Corporation | 997.09 Million USD | 96.867% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 95.71% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 98.016% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -14.247% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -14.247% |
| SCYNEXIS, Inc. | 128.41 Million USD | 75.67% |
| Safety Shot Inc | 12.7 Million USD | -145.83% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -35.093% |
| Alpha Teknova, Inc. | 128.58 Million USD | 75.703% |
| Bright Green Corporation | 17.4 Million USD | -79.526% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 84.818% |
| Embecta Corp. | 1.21 Billion USD | 97.427% |
| PainReform Ltd. | 9.93 Million USD | -214.632% |
| Journey Medical Corporation | 76.84 Million USD | 59.345% |
| Procaps Group, S.A. | 460.18 Million USD | 93.211% |
| Theratechnologies Inc. | 77.76 Million USD | 59.826% |
| Harrow Health, Inc. | 311.75 Million USD | 89.978% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -109.783% |
| Biofrontera Inc. | 27.93 Million USD | -11.854% |
| DURECT Corporation | 45.18 Million USD | 30.861% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 97.783% |
| Cronos Group Inc. | 1.13 Billion USD | 97.245% |
| OptiNose, Inc. | 107.72 Million USD | 70.999% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 93.368% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 44.158% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -35.561% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 93.208% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -162.146% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 61.794% |
| Radius Health, Inc. | 1.71 Billion USD | 98.179% |
| Universe Pharmaceuticals INC | 53.28 Million USD | 41.368% |
| ProPhase Labs, Inc. | 91.92 Million USD | 66.013% |
| Phibro Animal Health Corporation | 982.18 Million USD | 96.819% |
| Procaps Group S.A. | 460.18 Million USD | 93.211% |
| Alvotech | 950.09 Million USD | 96.712% |
| TherapeuticsMD, Inc. | 43.3 Million USD | 27.86% |
| Viatris Inc. | 47.68 Billion USD | 99.934% |
| Rockwell Medical, Inc. | 52.17 Million USD | 40.117% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 73.544% |
| SIGA Technologies, Inc. | 254.83 Million USD | 87.74% |
| Tilray Brands, Inc. | 4.33 Billion USD | 99.279% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 88.585% |
| Shineco, Inc. | 84.17 Million USD | 62.885% |
| PetIQ, Inc. | 868.22 Million USD | 96.402% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -270.256% |
| Incannex Healthcare Limited | 17.04 Million USD | -83.276% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 99.039% |
| Alimera Sciences, Inc. | 153.52 Million USD | 79.649% |
| Silver Spike Investment Corp. | 88.57 Million USD | 64.728% |
| Assertio Holdings, Inc. | 286.41 Million USD | 89.092% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -424.939% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | 7.554% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -135.84% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 88.035% |
| Hempacco Co., Inc. | 18.04 Million USD | -73.158% |
| Talphera, Inc. | 20.39 Million USD | -53.19% |
| Alvotech | 950.09 Million USD | 96.712% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 92.308% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 98.108% |
| Currenc Group, Inc. | 141.49 Million USD | 77.919% |
| Kamada Ltd. | 351.96 Million USD | 91.123% |
| Indivior PLC | 1.95 Billion USD | 98.399% |
| Evoke Pharma, Inc. | 7.06 Million USD | -342.0% |
| Flora Growth Corp. | 23.62 Million USD | -32.24% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -135.84% |
| Evolus, Inc. | 188.99 Million USD | 83.469% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 97.559% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 97.935% |
| Akanda Corp. | 8.83 Million USD | -253.428% |